Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Other Working Capital Changes (2021 - 2025)

PAVmed has reported Other Working Capital Changes over the past 5 years, most recently at -$23000.0 for Q4 2025.

  • Quarterly results put Other Working Capital Changes at -$23000.0 for Q4 2025, up 90.91% from a year ago — trailing twelve months through Dec 2025 was -$109000.0 (up 94.92% YoY), and the annual figure for FY2025 was -$109000.0, up 86.9%.
  • Other Working Capital Changes for Q4 2025 was -$23000.0 at PAVmed, up from -$345000.0 in the prior quarter.
  • Over the last five years, Other Working Capital Changes for PAVM hit a ceiling of $1.5 million in Q4 2021 and a floor of -$1.5 million in Q4 2023.
  • Median Other Working Capital Changes over the past 5 years was $151000.0 (2024), compared with a mean of $135000.0.
  • Biggest five-year swings in Other Working Capital Changes: plummeted 331.03% in 2022 and later surged 197.35% in 2025.
  • PAVmed's Other Working Capital Changes stood at $1.5 million in 2021, then plummeted by 162.34% to -$960000.0 in 2022, then crashed by 57.4% to -$1.5 million in 2023, then skyrocketed by 83.26% to -$253000.0 in 2024, then soared by 90.91% to -$23000.0 in 2025.
  • The last three reported values for Other Working Capital Changes were -$23000.0 (Q4 2025), -$345000.0 (Q3 2025), and $449000.0 (Q2 2025) per Business Quant data.